drugset / Trial / NCT01089322
Risk Factors Associated to Difficult-to-control Asthma
Phase 4
Completed
74 enrolled
Rafael Stelmach
Fundação de Amparo à Pesquisa do Estado de São Paulo · collab
NaSingle-groupOpen-labelTreatment
Summary
Several studies have demonstrated the efficacy of asthma treatment but despite being correctly diagnosed, conveniently prescribed and adherent to the therapeutics, 5% to 10% of asthmatics do not reach disease control. The aim of this study is to measure asthma control, evaluate inflammatory and functional characteristics, describe comorbidities and aggravating factors and phenotypes derived from the characteristics of a severe asthmatic population followed at an outpatient university service in Sao Paolo, Brazil.
Timeline
- Start
- 2005-12-09
- Primary completion
- 2009-04-03
- Completion
- 2009-05-13
Publications
- Athanazio R, Carvalho-Pinto R, Fernandes FL, Rached S, Rabe K, Cukier A, Stelmach R. Can severe asthmatic patients achieve asthma control? A systematic approach in patients with difficult to control asthma followed in a specialized clinic. BMC Pulm Med. 2016 Nov 16;16(1):153. doi: 10.1186/s12890-016-0314-1.
- de Carvalho-Pinto RM, Cukier A, Angelini L, Antonangelo L, Mauad T, Dolhnikoff M, Rabe KF, Stelmach R. Clinical characteristics and possible phenotypes of an adult severe asthma population. Respir Med. 2012 Jan;106(1):47-56. doi: 10.1016/j.rmed.2011.08.013. Epub 2011 Sep 3.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 400 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 12 ug | Inhaled |
| Subject | Prednisone | Other / unclassified | 40 mg | Oral |